Dolby Laboratories (DLB) | Financial Analysis & Statements

Dolby Laboratories Inc. | Mid-cap | Industrials

$75.56

-0.66%

Dolby Laboratories vs Cintas Dolby Laboratories vs Copart Dolby Laboratories vs Amentum Holdings Dolby Laboratories vs Maximus Dolby Laboratories vs CBIZ Dolby Laboratories vs S&P 500 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 1.3B

Gross Profit 1.1B 88.97%

Operating Income 264.7M 20.78%

Net Income 264.3M 20.75%

EPS (Diluted) $2.69

Balance Sheet Metrics

Total Assets 3.1B

Total Liabilities 623.0M

Shareholders Equity 2.5B

Debt to Equity 0.25

Cash Flow Metrics

Operating Cash Flow 356.9M

Free Cash Flow 297.2M

Revenue & Profitability Trend

Dolby Laboratories Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	1.3B	1.3B	1.3B	1.3B	1.2B
Cost of Goods Sold	140.5M	152.6M	141.4M	130.0M	146.5M
Gross Profit	1.1B	1.1B	1.1B	1.2B	1.0B
Operating Expenses	868.5M	884.4M	895.2M	810.5M	794.7M
Operating Income	264.7M	262.8M	217.2M	340.8M	220.6M
Pre-tax Income	312.5M	250.1M	215.3M	354.5M	239.7M
Income Tax	48.2M	48.4M	31.4M	36.7M	8.1M
Net Income	264.3M	201.6M	183.9M	317.8M	231.6M
EPS (Diluted)	$2.69	$2.05	$1.81	$2.97	$2.25

Income Statement Trend

Dolby Laboratories Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	1.2B	1.5B	1.3B	1.8B	1.5B
Non-Current Assets	1.9B	1.5B	1.4B	1.3B	1.4B
Total Assets	3.1B	3.0B	2.7B	3.1B	2.9B
Liabilities
Current Liabilities	417.8M	422.2M	277.5M	315.7M	267.1M
Non-Current Liabilities	205.2M	185.4M	161.0M	185.7M	211.8M
Total Liabilities	623.0M	607.6M	438.5M	501.5M	478.9M
Equity
Total Shareholders Equity	2.5B	2.4B	2.3B	2.6B	2.4B

Balance Sheet Composition

Dolby Laboratories Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	264.3M	201.6M	183.9M	317.8M	231.6M
Operating Cash Flow	356.9M	401.0M	336.5M	446.0M	341.0M
Investing Activities
Capital Expenditures	-30.0M	-30.3M	-47.9M	-54.5M	-66.3M
Investing Cash Flow	-286.3M	54.2M	-284.4M	-44.9M	137.0M
Financing Activities
Dividends Paid	-114.6M	-103.4M	-100.1M	-89.2M	-88.6M
Financing Cash Flow	-287.8M	-236.8M	-610.6M	-252.5M	-207.8M
Free Cash Flow	297.2M	336.7M	259.1M	393.3M	274.9M

Cash Flow Trend

Dolby Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 27.64

Forward P/E 19.15

Price to Book 2.72

Price to Sales 5.31

PEG Ratio 19.15

Profitability Ratios

Profit Margin 19.44%

Operating Margin 30.30%

Return on Equity 10.31%

Return on Assets 5.64%

Financial Health

Current Ratio 3.04

Debt to Equity 1.57

Beta 0.92

Per Share Data

EPS (TTM) $2.64

Book Value per Share $26.79

Revenue per Share $13.79

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
dlb	7.0B	27.64	2.72	10.31%	19.44%	1.57
Cintas	88.3B	50.73	19.22	40.30%	17.53%	58.62
Copart	46.1B	31.60	5.25	18.44%	32.21%	1.15
Amentum Holdings	5.3B	312.00	1.20	0.86%	0.14%	102.18
Maximus	3.9B	13.74	2.32	17.36%	5.56%	97.23
CBIZ	3.8B	59.75	1.92	6.25%	4.03%	101.92

Financial data is updated regularly. All figures are in the company's reporting currency.